APTA logo

Aptamer Group PLC Stock Price

AIM:APTA Community·UK£23.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

APTA Share Price Performance

UK£0
-0.00 (-100.00%)
UK£0
-0.00 (-100.00%)
Price UK£0

APTA Community Narratives

There are no narratives available yet.

Trending Discussion

Updated Narratives

No recently updated narratives available.

Snowflake Analysis

Flawless balance sheet with moderate risk.

5 Risks
0 Rewards

Aptamer Group PLC Key Details

UK£1.2m

Revenue

UK£624.0k

Cost of Revenue

UK£579.0k

Gross Profit

UK£3.0m

Other Expenses

-UK£2.4m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.0009
48.13%
-201.50%
0.7%
View Full Analysis

About APTA

Founded
2008
Employees
31
CEO
Arron Tolley
WebsiteView website
aptamergroup.com

Aptamer Group PLC, together with its subsidiaries, provides synthetic binders for research, diagnostics, and therapeutics in the United Kingdom, rest of Europe, the United States, and internationally. The company offers Optimer, a platform that enables the discovery and development of optimized DNA and RNA aptamers, which can bind to target molecules. Its platform is used in research reagent and analytical, bioprocessing, diagnostic, cosmetic and consumer health, and therapeutic applications. The company serves pharmaceutical, diagnostic, and bioprocessing companies. It has collaborations with Unilever, Neuro-Bio, the University of Glasgow, AstraZeneca, and Invizius. Aptamer Group PLC was founded in 2008 and is headquartered in York, the United Kingdom.

Recent APTA News & Updates

Recent updates

No updates